Wuxi AppTec Biologics Plans Share Repurchase of Up to $400 Million

GateNews
According to a Hong Kong Stock Exchange filing on May 26, Wuxi AppTec Biologics announced plans to repurchase up to $400 million worth of shares in open market transactions. The authorization was approved on May 24, 2026.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments